Y-Intercept (HK)’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Buy
23,617
+20,147
+581% +$1.83M 0.04% 634
2026
Q1
$334K Buy
+3,470
New +$347K 0.01% 1356
2024
Q3
Sell
-9,535
Closed -$419K 1550
2024
Q2
$419K Buy
+9,535
New +$406K 0.02% 896

Other funds holding IRMD

Y-Intercept (HK)'s IRMD Position: Q2 2026 in Review

Y-Intercept (HK) increased its iRadimed (IRMD) stake by 581% in Q2 2026, buying an estimated $1.83M and bringing the position to 23,617 shares worth $2.26M. The position accounts for 0.04% of the portfolio, ranked #634.

Y-Intercept (HK) first reported a position in IRMD in Q2 2024 and has held it in 3 quarters since. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Y-Intercept (HK) held 23,617 shares of iRadimed worth $2.26M as of Q2 2026.
  • Y-Intercept (HK) bought 20,147 iRadimed shares in Q2 2026, an estimated $1.83M.
  • iRadimed made up 0.04% of Y-Intercept (HK)'s portfolio in Q2 2026, its #634 holding.
  • Y-Intercept (HK) first reported a position in iRadimed in Q2 2024 and has held it in 3 quarters since.
  • 18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.